Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10

Clinical and Experimental Immunology

Volumn 104, Issue 3, 1996, Pages 483-490

  Kucharzik, T ^a   Lugering N ^a   Weigelt, H ^a   Adolf, M ^a   Domschke, W ^a   Stoll, R ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

IL 10; IL 13; IL 4; Inflammatory bowel disease; Monocytes

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREGULATION; MALE; MONOCYTE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0029999293     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.39750.x     Document Type: Article

References (38)

1. Mazlam MZ, Hodgson HJF. Peripheral blood monocyte production and acute phase response in inflammatory bowel disease. Gut 1992; 33:773-8.
2. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1987; 28:745-53.
3. Reinecker HC, Steffen M, Witthoeft, Pfleuger I, Schreiber S, McDermott RP, Raedler A. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94:174-81.
4. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer D. Relationship of functional and antigenic interleukin-6 to disease activity in inflammatory bowel disease. Gastroenterology 1993; 104:1285-92.
5. Mazlam MZ, Hodgson HJF. Interrelations between interleukin-6, interleukin-1β, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut 1994; 35:77-83.
6. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumor necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993; 34:1705-9.
7. Nikolopoulou V, Katsakoulis E, Tsiotos P. Thomopoulos, Salsaa K, Zoumbos N. Production of interleukin-1β and tumor necrosis factor α by peripheral blood human mononuclear cells in active and inactive stages of ulcerative colitis. Z Gastroenterol 1995; 33:9-12.
8. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut 1992; 33:933-7.
9. 2+-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 1995; 56:406-14.
10. Lügering N, Stoll R, Schmid KW et al. The myeloic related protein MRP8/14 (27E10 antigen) usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest 1995; 25:659-64.
11. Isaacs KL, Sartor RB, Haskill JS. Cytokine mRNA profiles in inflammatory bowel disease mucosa detected by PCR amplification. Gastroenterology 1992; 103:1587-95.
12. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-35.
13. Kucharzik T, Stoll R, Lügering N, Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease. Clin Exp Immunol 1995; 100:452-6.
14. Radford-Smith G, McGowan I, Jewell DP. Th1 and Th2 gene expression in inflammatory bowel disease (Abstr.). Gastroenterology 1994; 106: A757.
15. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-9.
16. Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ. Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 1993; 51:3370-80.
17. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 1995; 99:331-9.
18. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A. Impaired response of activated mononuclear phagocytes to interleukin-4 in inflammatory bowel disease. Gastroenterology 1995; 108:21-33.
19. Schreiber S, Heinig T, Thiele H-G, Raedler A. Immunoregulatory role of interleukin-10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108:1434-44.
20. Zurawski G, De Vries JE. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T-cells Immunol Today 1994; 15:19-26.
21. Minty A, Chalon P, Derocq J-M et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50.
22. McKenzie ANJ, Culpepper JA, De Waal Malefyt R et al. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90:3735-9.
23. McKenzie ANJ, Li X, Largaespada DA et al. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 1993; 150:5436-44.
24. De Waal Malefyt R, Figdor CG, Huijbens R et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ, or IL-10. J Immunol 1993; 151:6370-81.
25. McKenzie ANJ, Culpepper JA, De Waal Malefyt R et al. Interleukin-13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression on human B cells. Proc Natl Acad Sci USA 1993; 90:3730-4.
26. Young DA, Lowe LD, Clark SC. Comparison of effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody dependent cellular cytotoxicity. J Immunol 1990; 145:607-15.
27. Rutherford MS, Witsell A, Schock LB. Mechanisms generating functionally heterogenous macrophages: chaos revisited. J Leukocyte Biol 1993; 48:43-49.
28. Rachmilewitz D. Coated mesalazine (5-amino-salicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 1989; 198:82-86.
29. Best WR, Becktel JM, Singleton JW, Kern FR. Development of a Crohn's disease activity index: national cooperative Crohn's disease study. Gastroenterology 1976; 101:782-5.
30. Feige U, Overwien B, Sorg C. Purification of human blood monocytes by hypotonie density gradient centrifugation in Percoll. J Immunol Methods 1982; 54:309-15.
31. Donnelly RP, Fenton MJ, Finbloom DS, Gerrard TL. Differential regulation of IL-1 production in human monocytes by IFN-y and IL-4. J Immunol 1990; 145:569-75.
32. Mazlam ZM, Montazeri G, Hodgson HJF. The effects of some antiinflammatory agents on cytokine release from human monocytes in vitro. Eur J Gastroenterol Hepatol 1993; 5:515-20.
33. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor-α production. J Exp Med 1995; 181:537-46.
34. Florentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen presenting cells to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
35. Hart PH, Jones CA, Finlay-Jones JJ. Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and 1L-10. J Leukocyte Biol 1995; 57:909-18.
36. Baldassano RN, Schreiber S, Johnston RB, Muraki T, MacDermott RP. Monocytes of patients with Crohn's disease are primed for accentuated release of toxic oxygen metabolites: possible role for endotoxin. Gastroenterology 1993; 105:60-66.
37. Zurawski SM, Vega F Jr, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO-J 1993; 12:2663-70.
38. Aversa G, Punnonen J, Cocks BG et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulia G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993; 178:2213-8.